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One of the most intriguing aspects of urologic prac-tice is the drive our field has toward innovation. Often,
these innovations are adapted from other applications or
fields, as is the case for the ‘‘Y’’ intracorporeal neobladder
from Sim and colleagues. This group took a technique that
was vetted in the open experience1 and adapted it to the robotic
approach. Others have reported the feasibility of performing an
intracorporeal neobladder, but the majority of these used the
more common folded, spherical (e.g., Studer) pouch. Although
successful, constructing these neobladders necessitates an ex-
orbitant amount of cumbersome intracorporeal manipulation,
and at least in most hands, results in excessive operative times.
There are some operative and functional advantages of the
‘‘Y’’ over the spherical neobladders. The ‘‘Y’’ requires an
ileal segment that is up to 20 cm shorter. This likely impacts
the patient’s bowel absorptive function minimally, but the
shorter bowel segment is easier to manage intracorporeally
and takes less time to detubularize and sew. The use of the
‘‘double-chimney’’ configuration has been described in open
surgery previously in conjunction with a Hautmann spherical
neobladder.2 This obviates the need to tunnel the left ureter
under or through the sigmoid mesocolon resulting in a shorter
remaining segment of left ureter, thus reducing the ischemic
strain on the distal ureter. This may help avoid anastomotic
stricture.
There is also an oncologic advantage of this design: A
shorter retained segment of left ureter reduces the risk of
future recurrence, especially in cases of carcinoma in situ. In
the event of upper tract recurrence, diagnosis may be facili-
tated with more straightforward access to the lone ureteral
anastomosis in each limb, and nephroureterectomy with
completion ureterectomy for left-sided tumors would be
simpler, avoiding the need to dissect the distal segment from
under the mesocolon.
Of course the crucial overriding question on this topic is:
‘‘Does cystectomy with intracorporeal neobladder result in
added patient benefit over the open approach?’’ Simply
providing evidence of equivalence is insufficient cause to
promote this technique. The added cost and the investment in
the collective learning curve are too great to promote an
equivalent approach. There is mounting evidence of accept-
able oncologic results with robotic cystectomy.3 Improving
the relative dismal oncologic outcomes for muscle-invasive
bladder cancer likely relies more on promoting early cy-
stectomy, the wider use of neoadjuvant chemotherapy, and
innovations in genomic-based personalized therapeutics.
Sound surgical technique is crucial, but in experienced hands
will only get patients so far.
Therefore, if the marginal benefits resulting from total
intracorporeal cystectomy do not lie in the oncologic realm,
they must be in patient convalescence, complication, and
quality of life advantages. The outcomes from series looking
at robot-assisted cystectomy with open urinary diversion are
mixed.4 As with all robotic procedures, blood loss is signif-
icantly diminished, but similar lengths of stay, complication
rates, and rates of readmission indicate that this approach is
no windfall. Despite the minimally invasive nature, patient
benefits have been inconsistent. Perhaps robot-assisted cy-
stectomy with intracorporeal urinary diversion is the answer
we are looking for to reduce the morbidity of this procedure.
Time will tell, but innovations like the intracorporeal ‘‘Y’’
neobladder are crucial to help advance the technique of robot-
assisted cystectomy.
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